Clinical trial
A Prospective, Multicenter, Single Arm Study to Obtain Additional Data on the Safety and Efficacy of the Express Vascular LD Implantation in the Treatment of Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries
NCT00352222 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Single Arm Study to Obtain Additional Data on the Safety and Efficacy of the Express Vascular LD Implantation in the Treatment of Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2004
- Completion date
- February 28, 2007
- Enrollment
- 150
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
arterial occlusive disease, atherosclerotic disease, intermittent claudication, thrombosis